Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Alembic Pharmaceuticals Limited
Press Release Jun 18 2024
Business
Jun 18 2024
5 min read

Press Release Jun 18 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 18, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg".

View Attachment